Personal information

Emails & domains

Verified email addresses

Verified email domains

Websites & social links

Google Scholar

Countries

Pakistan, China, Australia

Activities

Collapse all

Employment (3)

The University of South Australia: Adelaide, AU

Employment
Source: check_circle
The University of South Australia

Beijing Institute of Technology: Beijing, Beijing, CN

2021-04-12 to present | Postdoctoral Fellow (Advanced Research Institute for Multidisciplinary Science)
Employment
Source: Self-asserted source
Dr. Abid Hussain

Anovent Pharmaceutical Co., Ltd: Shanghai, Shanghai, CN

2019-07-01 to 2021-02-26 | Senior Manager (Formulation R&D)
Employment
Source: Self-asserted source
Dr. Abid Hussain

Education and qualifications (1)

Shanghai Jiao Tong University: Shanghai, Shanghai, CN

2015-09-13 to 2019-06-30 | Ph.D. in Pharmacy (School of Pharmacy)
Education
Source: Self-asserted source
Dr. Abid Hussain

Works (34)

Development of Glycan-masked SARS-CoV-2 RBD vaccines against SARS-related coronaviruses

PLOS Pathogens
2024-09-26 | Journal article
DOI: 10.1371/journal.ppat.1012599
Part of ISSN: 1553-7374
Contributors: Zuxin Liang; Chunhui Li; Xiaohua Gong; Guoguo Ye; Yushan Jiang; Huiping Shi; Abid Hussain; Mengyuan Zhao; Mengjun Li; Yuxin Tian et al.
Source: Self-asserted source
Dr. Abid Hussain

Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA

Nature Communications
2024-07-31 | Journal article
DOI: 10.1038/s41467-024-50752-9
Contributors: Mengjie Zhang; Abid Hussain; Bo Hu; Haiyin Yang; Chunhui Li; Shuai Guo; Xiaofeng Han; Bei Li; Yunlu Dai; Yuhong Cao et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Exosome regulation of immune response mechanism: Pros and cons in immunotherapy

Bioactive Materials
2024-02 | Journal article
DOI: 10.1016/j.bioactmat.2023.09.018
Part of ISSN: 2452-199X
Contributors: Julien Milon Essola; Mengjie Zhang; Haiyin Yang; Fangzhou Li; Bozhang Xia; Jacques François Mavoungou; Abid Hussain; Yuanyu Huang
Source: Self-asserted source
Dr. Abid Hussain

The landscape of nanoparticle-based siRNA delivery and therapeutic development

Molecular Therapy
2024-02 | Journal article
DOI: 10.1016/j.ymthe.2024.01.005
Part of ISSN: 1525-0016
Contributors: Muhammad Moazzam; Mengjie Zhang; Abid Hussain; Xiaotong Yu; Jia Huang; Yuanyu Huang
Source: Self-asserted source
Dr. Abid Hussain

Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity

Signal Transduction and Targeted Therapy
2024-02-14 | Journal article
DOI: 10.1038/s41392-024-01748-w
Part of ISSN: 2059-3635
Contributors: Minghui Yang; Chunhui Li; Guoguo Ye; Chenguang Shen; Huiping Shi; Liping Zhong; Yuxin Tian; Mengyuan Zhao; Pengfei Wu; Abid Hussain et al.
Source: Self-asserted source
Dr. Abid Hussain

mRNA-based modalities for infectious disease management

Nano Research
2023 | Journal article | Author
DOI: 10.1007/s12274-022-4627-5
HANDLE: 11541.2/36871
Part of ISSN: 1998-0124
EID:

2-s2.0-85133601357

WOSUID:

000823229400007
Contributors: Dr. Abid Hussain; Zhang, Jinchao; Yang, Haiyin; Huang, Yuanyu; Liang, Xing Jie; Zhang, Mengjie
Source: check_circle
The University of South Australia

Lipid-conjugated siRNA hitchhikes endogenous albumin for tumor immunotherapy

Chinese Chemical Letters
2023-02 | Journal article
DOI: 10.1016/j.cclet.2023.108210
Part of ISSN: 1001-8417
Contributors: Bo Hu; Sudong Kong; Yuhua Weng; Deyao Zhao; Abid Hussain; Qingze Jiao; Shijing Zhan; Ling Qiu; Jianguo Lin; Minhao Xie et al.
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

A new approach based on CXCR4-targeted combination liposomes for the treatment of liver fibrosis

Biomaterials Science
2022 | Journal article
DOI: 10.1039/d2bm00242f
Part of ISSN: 2047-4830
Part of ISSN: 2047-4849
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Advances in mRNA delivery and clinical applications

2022 | Book chapter | Author
DOI: 10.1007/978-3-031-08415-7_13
HANDLE: 11541.2/36862
Part of ISBN: 9783031084140
EID:

2-s2.0-85139043731
Contributors: Dr. Abid Hussain; Weng, Yuhua; Hu, Bo; Huang, Yuanyu; Liu, Qing
Source: check_circle
The University of South Australia

Advances in mRNA Delivery and Clinical Applications

Messenger RNA Therapeutics
2022 | Book chapter
Contributors: Dr. Abid Hussain
Source: Self-asserted source
Dr. Abid Hussain

Herbal bioactive–based nano drug delivery systems

Herbal Bioactive-Based Drug Delivery Systems
2022 | Book chapter
DOI: 10.1016/b978-0-12-824385-5.00011-x
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations

Journal of Nanobiotechnology
2022-12 | Journal article
DOI: 10.1186/s12951-022-01451-4
Part of ISSN: 1477-3155
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

mRNA-based modalities for infectious disease management

Nano Research
2022-07-06 | Journal article
Source: Self-asserted source
Dr. Abid Hussain

siRNA-functionalized lanthanide nanoparticle enables efficient endosomal escape and cancer treatment

Nano Research
2022-06-25 | Journal article
DOI: 10.1007/s12274-022-4573-2
Part of ISSN: 1998-0124
Part of ISSN: 1998-0000
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

mRNA vaccines for COVID-19 and diverse diseases

Journal of Controlled Release
2022-05 | Journal article
DOI: 10.1016/j.jconrel.2022.03.032
Part of ISSN: 0168-3659
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia

Science Advances
2022-02-18 | Journal article
DOI: 10.1126/sciadv.abm1418
Part of ISSN: 2375-2548
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Pharmaceutical formulation containing combination of m3 antagonist-beta-2 agonist and inhaled corticosteroids

WO2022006028A3 WIPO (PCT)
2022-02-10 | Patent | Supervision
Contributors: Dr. Abid Hussain
Source: Self-asserted source
Dr. Abid Hussain

Osteopontin targeted theranostic nanoprobes for laser-induced synergistic regression of vulnerable atherosclerotic plaques

Acta Pharmaceutica Sinica B
2021-12-31 | Journal article
DOI: 10.1016/j.apsb.2021.12.020
Part of ISSN: 2211-3835
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Pharmaceutical formulation containing remdesivir and its active metabolites for dry powder inhalation

WO2021236570A1 WIPO (PCT)
2021-11-25 | Patent | Supervision, Data curation, Formal analysis, Investigation, Methodology, Validation, Writing - original draft, Conceptualization, Software
Contributors: Dr. Abid Hussain
Source: Self-asserted source
Dr. Abid Hussain

Graphene and Graphene-Based Nanomaterials

Drug Delivery Using Nanomaterials
2021-11-17 | Book chapter
DOI: 10.1201/9781003168584-9
Part of ISBN: 9781003168584
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Progress of Photodynamic and RNAi Combination Therapy in Cancer Treatment

ACS Biomaterials Science & Engineering
2021-09-13 | Journal article
DOI: 10.1021/acsbiomaterials.1c00765
Part of ISSN: 2373-9878
Part of ISSN: 2373-9878
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Membrane‐destabilizing ionizable lipid empowered imaging‐guided siRNA delivery and cancer treatment

Exploration
2021-08 | Journal article
DOI: 10.1002/exp.20210008
Part of ISSN: 2766-2098
Part of ISSN: 2766-2098
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Assessment of public intention to get vaccination against COVID ‐19: Evidence from a developing country

Journal of Evaluation in Clinical Practice
2021-08-23 | Journal article
DOI: 10.1111/jep.13611
Part of ISSN: 1356-1294
Part of ISSN: 1365-2753
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis

International Journal of Nanomedicine
2021-07 | Journal article
DOI: 10.2147/ijn.s314367
Part of ISSN: 1178-2013
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Ionizable lipid-assisted efficient hepatic delivery of gene editing elements for oncotherapy

Bioactive Materials
2021-06 | Journal article
DOI: 10.1016/j.bioactmat.2021.05.051
Part of ISSN: 2452-199X
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Core Role of Hydrophobic Core of Polymeric Nanomicelle in Endosomal Escape of siRNA

Nano Letters
2021-04-28 | Journal article
DOI: 10.1021/acs.nanolett.0c04468
Part of ISSN: 1530-6984
Part of ISSN: 1530-6992
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Liposome formulation of fluticasone furoate and method of preparation

WO2021041374A1 WIPO (PCT)
2021-03-04 | Patent | Project administration, Conceptualization, Data curation, Investigation, Methodology, Validation, Writing - original draft
Contributors: Dr. Abid Hussain
Source: Self-asserted source
Dr. Abid Hussain

NIR-triggered release of DOX from sophorolipid-coated mesoporous carbon nanoparticles with the phase-change material 1-tetradecanol to treat MCF-7/ADR cells

Journal of Materials Chemistry B
2019 | Journal article
DOI: 10.1039/c8tb02673d
Part of ISSN: 2050-750X
Part of ISSN: 2050-7518
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Pyrazinamide resistance and mutations L19R, R140H, and E144K in Pyrazinamidase of Mycobacterium tuberculosis

Journal of Cellular Biochemistry
2019-05 | Journal article
DOI: 10.1002/jcb.27989
Part of ISSN: 0730-2312
Part of ISSN: 1097-4644
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Nanodiamond mediated co-delivery of doxorubicin and malaridine to maximize synergistic anti-tumor effects on multi-drug resistant MCF-7/ADR cells

Journal of Materials Chemistry B
2017 | Journal article
DOI: 10.1039/c7tb00449d
Part of ISSN: 2050-750X
Part of ISSN: 2050-7518
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Photothermal gold nanocages filled with temperature sensitive tetradecanol and encapsulated with glutathione responsive polycurcumin for controlled DOX delivery to maximize anti-MDR tumor effects

Journal of Materials Chemistry B
2017 | Journal article
DOI: 10.1039/c7tb01253e
Part of ISSN: 2050-750X
Part of ISSN: 2050-7518
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

PEGylated Doxorubicin Micelles Loaded with Curcumin Exerting Synergic Effects on Multidrug Resistant Tumor Cells

Journal of Nanoscience and Nanotechnology
2017-05-01 | Journal article
DOI: 10.1166/jnn.2017.13047
Part of ISSN: 1533-4880
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Phenolic, flavonoid contents, anticholinesterase and antioxidant evaluation of Iris germanica var; florentina

Natural Product Research
2016-06-17 | Journal article
DOI: 10.1080/14786419.2015.1057585
Part of ISSN: 1478-6419
Part of ISSN: 1478-6427
Source: Self-asserted source
Dr. Abid Hussain
grade
Preferred source (of 2)‎

Anticholinesterse and antioxidant investigations of crude extracts, subsequent fractions, saponins and flavonoids of atriplex laciniata L.: potential effectiveness in Alzheimer’s and other neurological disorders

Biological Research
2015-12 | Journal article
DOI: 10.1186/s40659-015-0011-1
Part of ISSN: 0717-6287
Source: Self-asserted source
Dr. Abid Hussain

Peer review (28 reviews for 10 publications/grants)

Review activity for Advanced science. (3)
Review activity for Healthcare. (3)
Review activity for International journal of molecular sciences. (3)
Review activity for Journal of clinical medicine. (3)
Review activity for Journal of personalized medicine. (3)
Review activity for Life. (2)
Review activity for Non-coding RNA. (2)
Review activity for Pharmaceuticals. (2)
Review activity for RSC advances (3)
Review activity for Vaccines. (4)
How many people are using ORCID?